Cargando…
MicroRNAs and Polycystic Kidney Disease
Important advances have been made regarding the diagnosis and management of polycystic kidney diseases. Care of patients with polycystic kidney diseases has moved beyond supportive care for complications and chronic kidney disease to new potentially disease-modifying therapies. Recently, the role of...
Autores principales: | Li, Dantong, Sun, Liangzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729224/ https://www.ncbi.nlm.nih.gov/pubmed/33319200 http://dx.doi.org/10.1016/j.xkme.2020.06.013 |
Ejemplares similares
-
Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease
por: Tangri, Navdeep, et al.
Publicado: (2017) -
Polycystic Ovarian Syndrome and Menopause in Forty Plus Women
por: Sharma, Sudhaa, et al.
Publicado: (2021) -
The role of altered microRNA expression in premalignant and malignant head and neck lesions with epithelial origin
por: Farshbaf, Alieh, et al.
Publicado: (2022) -
Role of Toxic Elements in Chronic Kidney Disease
por: Fevrier-Paul, Adwalia, et al.
Publicado: (2018) -
Found in Translation: Reasons for Optimism in the Pursuit to Prevent
Chronic Kidney Disease After Acute Kidney Injury
por: Silver, Samuel A., et al.
Publicado: (2019)